Peibing Qin

Peibing Qin is currently the Director of Biostatistics at Supernus Pharmaceuticals, Inc., a position held since November 2018, with prior experience as Associate Director and Assistant Director in Biostatistics within the same organization. Responsibilities include clinical trial design, protocol statistical sections, oversight of CRO work, and FDA interaction. Earlier roles include Principal Biostatistician at Personal Genome Diagnostics, Contract Statistician at Takeda Oncology, and Statistician at BD, where Peibing focused on sample size estimation, data analyses, and regulatory submissions. Initial experience began at Abbott Laboratories, contributing to protocol design and quality assurance in clinical data analysis. Peibing holds a Ph.D. in Biology and Statistics from Syracuse University, obtained between 2001 and 2007.